DeGraffenried et al. showed that there is an increase in NF-κB activity in the tamoxifen-resistant BC cell lines, but the study did not report a relationship between the high activity of NF-κB and ABC transporters (28). This evidence concerns the gene ABCG2 and breast cancer.